Cover Image

Value of venous thromboembolism prophylaxis by enoxaparin with anti-factor Xa trough concentration monitoring in surgical care

Fuente: Redalyc

Saved in:

Bibliographic Details
Main Author:	Seeba Zachariah
Format:	Artículo científico
Language:	en
Published:	Centro de investigaciones y Publicaciones Farmacéuticas 2020
Subjects:	Medicina
Online Access:	Acceder al recurso 1 Acceder al recurso 2 Acceder al recurso 3 Acceder al recurso 4 Acceder al recurso 5
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Randomized, controlled, multi‐center phase II study of postoperative enoxaparin treatment for venous thromboembolism prophylaxis in patients undergoing surgery for hepatobiliary‐pancreatic malignancies
by: Go Shinke, et al.
Published: (2024)

Pharmacist recommendations for prophylactic enoxaparin monitoring and dose adjustment in trauma patients admitted to a surgical intensive care unit
by: Ali Scrimenti
Published: (2019)

New anticoagulants for venous thromboembolism prophylaxis in major orthopedic surgeries. A systematic review of randomized controlled trials
by: Ricardo de Alvarenga Yoshida
Published: (2012)

Clinical significance of recurrent venous thromboembolism
by: Nicos Labropoulos
Published: (2010)

Intravenous enoxaparin guided by anti‐Xa in venovenous extracorporeal membrane oxygenation: A retrospective, single‐center study
by: Miroslav Durila, et al.
Published: (2024)

Estimated impact of model‐guided venous thromboembolism prophylaxis versus real‐world practice
by: Benjamin G Mittman, et al.
Published: (2026)

Hospital‐associated venous thromboembolism prophylaxis use by risk assessment at a large integrated health care network in Northern California
by: James Xu, et al.
Published: (2024)

Safety and efficacy of anti‐coagulation for primary and secondary venous thromboembolism prophylaxis in hospitalized adolescents and young adults with sickle cell disease: An institutional experience
by: Vilmarie Rodriguez, et al.
Published: (2026)

Assessment of non-cardiac surgical patients using the ACS-NSQIP calculator to predict the risk of pneumonia, cardiac complications and venous thromboembolism
by: INDHIRA PACHANO-GARCÍA
Published: (2021)

Multicenter study evaluating target attainment of anti‐Factor Xa levels using various enoxaparin prophylactic dosing practices in adult trauma patients
by: Tyler Chanas, et al.
Published: (2024)

Individualización posológica de enoxaparina en un obeso extremo mediante la monitorización del factor anti-Xa
by: Arantxa Andujar Mateos
Published: (2016)

Clonal haemopoiesis and venous thromboembolism risk
by: David P. Steensma
Published: (2024)

A descriptive study of antithrombotic medication patterns in adult patients with recent venous thromboembolism
by: Fady Allahwerdy
Published: (2019)

Risk factors for deep venous thrombosis in patients undergoing orthopedic surgical procedures
by: Marco Antonio González Fuenmayor
Published: (2022)

DOAC‐Remove to counteract the interference of anti‐Xa oral anticoagulants on the monitoring of heparin
by: Sophie Melicine, et al.
Published: (2024)

New horizons in the pharmacological management of venous thromboembolism
by: Andreas Verstraete, et al.
Published: (2025)

Navigating venous thromboembolism risks in lung cancer patients
by: Si‐Wai Vivian Chiu, et al.
Published: (2024)

Peculiaridades da terapia trombolítica na síndrome nefrótica pediátrica: monitorização do fator anti-Xa
by: Patrícia Zambi Meirelles
Published: (2008)

Venous thromboembolism prevention protocol for adapting prophylaxis recommendations to the potential risk post total knee replacement: a randomized controlled trial
by: Mariam A. Alameri
Published: (2020)

Differential risks of venous thromboembolic events in pemphigus and pemphigoid diseases
by: Maren E. Buenning, et al.
Published: (2025)

Clinical guideline highlights for the hospitalist: Management of pediatric venous thromboembolism
by: Carly Noel, et al.
Published: (2026)

Efficacy and safety of bemiparin as treatment of venous thromboembolic disease in the elderly
by: Javier Ena, et al.
Published: (2024)

Attention to the risk of venous thromboembolism in mechanically restrained hospitalised patients
by: Adrian Chee, et al.
Published: (2024)

Interpreting the risk of venous thromboembolism with JAK inhibitors in atopic dermatitis
by: Sheng Li, et al.
Published: (2025)

Cost-effectiveness analysis of apixaban compared to low-molecular-weight heparins and vitamin k antagonists for treatment and secondary prevention of venous thromboembolism
by: Isabel Elías
Published: (2016)

Association between venous thromboembolism‐associated genetic variants, coagulation factor levels, and thrombin generation potential
by: Jihee Han, et al.
Published: (2024)

Associations of blood pressure in the third trimester and risk of venous thromboembolism postpartum
by: Qian Li, et al.
Published: (2024)

Potency evaluation of unfractionated heparins commercialized in Brazil through anti-factor Xa and anti-factor IIa chromogenic tests and coagulation assay
by: Renata Jurema Medeiros
Published: (2023)

The efficacy of aspirin versus low‐molecular‐weight heparin for venous thromboembolism prophylaxis after knee and hip arthroplasty: A systematic review and meta‐analysis of randomized controlled trials
by: Loay A. Salman, et al.
Published: (2024)

Prevalence of risk factors for venous thromboembolism and aspirin resistance in Australian patients undergoing total hip and knee arthroplasty
by: Nameer van Oosterom, et al.
Published: (2024)

Pulmonary thromboembolism in an anticoagulated oncological patient
by: Diana Alegre-González
Published: (2023)

Three cases of neutralization of factor Xa inhibitors with andexanet alfa under rotational thromboelastography monitoring
by: Takeshi Yagi, et al.
Published: (2024)

Comparison of four D ‐dimer assays in the context of venous thromboembolism in the emergency department
by: Fabio Del Ben, et al.
Published: (2024)

Advances and current research in primary thromboprophylaxis to prevent hospital‐associated venous thromboembolism
by: Lara N. Roberts, et al.
Published: (2024)

Symptomatic and asymptomatic venous thromboembolism after minimally invasive surgery for gynecological cancers
by: Michiko Kubo‐Kaneda, et al.
Published: (2025)

Vancomycin use, dosing and serum trough concentrations in the pediatric population: a retrospective institutional review
by: Kevin Rajon
Published: (2017)

Does in vitro hemolysis affect measurements of plasma apixaban concentration by UPLC‐MS and anti‐Xa assay?
by: Henriette Røed‐Undlien, et al.
Published: (2024)

Current surgical management of chronic thromboembolic pulmonary disease
by: Hayley Barnes, et al.
Published: (2024)

Synchronous eyelid oncocytoma and conjunctival intraepithelial neoplasia
by: Zachariah Chowdhury
Published: (2021)

Fatal pulmonary thromboembolism associated with uterine carcinosarcoma
by: Giorgia Lodetti
Published: (2023)